These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29630525)

  • 1. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
    Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
    Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
    Shi L; Xie C; Zhu J; Chen X
    Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
    Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
    Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
    Yuan J; Chen L; Chen X; Sun W; Zhou X
    J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
    J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.
    Cao L; Wang J; Wang PQ
    Biomed Pharmacother; 2016 Dec; 84():828-835. PubMed ID: 27723574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.
    Cai H; Zhao H; Tang J; Wu H
    J Surg Res; 2015 Apr; 194(2):505-510. PubMed ID: 25498513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.
    Ma W; Zhang X; Chai J; Chen P; Ren P; Gong M
    Tumour Biol; 2014 Dec; 35(12):12467-72. PubMed ID: 25185654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
    Wang T; Ji F; Dai Z; Xie Y; Yuan D
    Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study.
    Xie XY; Chen XM; Shi L; Liu JW
    Medicine (Baltimore); 2021 Mar; 100(12):e24765. PubMed ID: 33761638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.